Membrane interactions of designed cationic antimicrobial peptides: the two thresholds - PubMed (original) (raw)
Membrane interactions of designed cationic antimicrobial peptides: the two thresholds
Evgenia Glukhov et al. Biopolymers. 2008 May.
Abstract
Novel cationic antimicrobial peptides (CAPs) designed in our lab-typified by sequences such as KKKKKKAAX-AAXAAXAA-NH(2), where X = Phe/Trp-display high antibacterial activity but exhibit little or no hemolytic activity towards human red blood cells even at high doses. To clarify the mechanism of their selectivity for bacterial versus mammalian membranes and to increase our understanding of the relationships between primary sequence and bioactivity, a library of derivatives was prepared by increasing segmental hydrophobicity, in which systematic substitutions of Ala for two, three, or four Leu residues were made. Conformationally constrained dimeric and cyclic derivatives were also synthesized. The peptides were examined for activity against pathogenic bacteria (Pseudomonas aeruginosa), hemolytic activity on human red blood cells, and insertion into models of natural bacterial membranes (containing anionic lipids) and mammalian membranes (containing zwitterionic lipids + cholesterol). Results were compared with corresponding properties of the natural CAPs magainin and cecropin. Using circular dichroism and fluorescence spectroscopy, we found that peptide conformation and membrane insertion were sequence dependent, both upon the number of Leu residues, and upon their positions along the hydrophobic core. Membrane disruption was likely enhanced by the fact that the peptides contain potent dimerization-promoting sequence motifs, as assessed by SDS-PAGE gel analysis. The overall results led us to identify distinctions in the mechanism of actions of these CAPs for disruption of bacterial versus mammalian membranes, the latter dependent on surpassing a "second hydrophobicity threshold" for insertion into zwitterionic membranes.
Similar articles
- Sequence requirements and an optimization strategy for short antimicrobial peptides.
Hilpert K, Elliott MR, Volkmer-Engert R, Henklein P, Donini O, Zhou Q, Winkler DF, Hancock RE. Hilpert K, et al. Chem Biol. 2006 Oct;13(10):1101-7. doi: 10.1016/j.chembiol.2006.08.014. Chem Biol. 2006. PMID: 17052614 - New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.
Cerovský V, Slaninová J, Fucík V, Hulacová H, Borovicková L, Jezek R, Bednárová L. Cerovský V, et al. Peptides. 2008 Jun;29(6):992-1003. doi: 10.1016/j.peptides.2008.02.007. Epub 2008 Feb 19. Peptides. 2008. PMID: 18375018 - Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL, Lan H, Park Y, Yang ST, Kim JI, Park IS, You HJ, Lee JS, Park YS, Kim Y, Hahm KS, Shin SY. Zhu WL, et al. Biochemistry. 2006 Oct 31;45(43):13007-17. doi: 10.1021/bi060487+. Biochemistry. 2006. PMID: 17059217 - Design and synthesis of antimicrobial peptides.
Merrifield RB, Merrifield EL, Juvvadi P, Andreu D, Boman HG. Merrifield RB, et al. Ciba Found Symp. 1994;186:5-20; discussion 20-6. Ciba Found Symp. 1994. PMID: 7768157 Review. - Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?
Papo N, Shai Y. Papo N, et al. Peptides. 2003 Nov;24(11):1693-703. doi: 10.1016/j.peptides.2003.09.013. Peptides. 2003. PMID: 15019200 Review.
Cited by
- Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities.
Henriques ST, Huang YH, Rosengren KJ, Franquelim HG, Carvalho FA, Johnson A, Sonza S, Tachedjian G, Castanho MA, Daly NL, Craik DJ. Henriques ST, et al. J Biol Chem. 2011 Jul 8;286(27):24231-41. doi: 10.1074/jbc.M111.253393. Epub 2011 May 16. J Biol Chem. 2011. PMID: 21576247 Free PMC article. - Peptide-Based Efflux Pump Inhibitors of the Small Multidrug Resistance Protein from Pseudomonas aeruginosa.
Mitchell CJ, Stone TA, Deber CM. Mitchell CJ, et al. Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00730-19. doi: 10.1128/AAC.00730-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31209007 Free PMC article. - Antibacterial mechanism of action of arylamide foldamers.
Mensa B, Kim YH, Choi S, Scott R, Caputo GA, DeGrado WF. Mensa B, et al. Antimicrob Agents Chemother. 2011 Nov;55(11):5043-53. doi: 10.1128/AAC.05009-11. Epub 2011 Aug 15. Antimicrob Agents Chemother. 2011. PMID: 21844313 Free PMC article. - Piloting the membranolytic activities of peptides with a self-organizing map.
Lin YC, Hiss JA, Schneider P, Thelesklaf P, Lim YF, Pillong M, Koehler FM, Dittrich PS, Halin C, Wessler S, Schneider G. Lin YC, et al. Chembiochem. 2014 Oct 13;15(15):2225-31. doi: 10.1002/cbic.201402231. Epub 2014 Sep 9. Chembiochem. 2014. PMID: 25204788 Free PMC article. - Peptide/β-Peptoid Hybrids with Ultrashort PEG-Like Moieties: Effects on Hydrophobicity, Antibacterial Activity and Hemolytic Properties.
Frederiksen N, Louka S, Mudaliar C, Domraceva I, Kreicberga A, Pugovics O, Żabicka D, Tomczak M, Wygoda W, Björkling F, Franzyk H. Frederiksen N, et al. Int J Mol Sci. 2021 Jun 30;22(13):7041. doi: 10.3390/ijms22137041. Int J Mol Sci. 2021. PMID: 34208826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous